A study showed meningitis B vaccines like GlaxoSmithKline’s Bexsero can provide some protection against gonorrhea, but the company wouldn’t be satisfied with “some.” Instead, it’s considering developing an entirely new—and more effective—vaccine against the resurgent STD.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,